More articles from Brain tumors

You have access
Discriminative power of dynamic [18F]FET-PET in MRI-suspected low grade glioma
Nathalie Jansen, Vera Graute, Bogdana Suchorska, Juergen Lutz, Friedrich Kreth, Peter Bartenstein and Christian la Fougere

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 252;
You have access
Role of [18F]fluoroethyl-L-tyrosine PET for differentiation of radiation necrosis from recurrent brain metastasis
Norbert Galldiks, Gabriele Stoffels, Christian Filss, Marc Piroth, Michael Sabel, Maximilian Ruge, Nadim Joni Shah, Gereon Fink, Heinrich Hubert Coenen and Karl-Josef Langen

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 251;
You have access
Simultaneous [18F]FET PET/MR in cerebral tumors. Comparison with conventional PET/CT
Michael Souvatzoglou, Sebastian Fürst, Matthias Eiber, Stephan Nekolla, Sibylle Ziegler, Coletta Kruschke, Anna Winter, Markus Schwaiger and Alexander Drzezga

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 256;
You have access
Comparison of [F-18]fluoroethyl-L-tyrosine (FET) PET and perfusion weighted MR-imaging (PWI) in brain tumors
Christian Filss, Hans Wittsack, Gabriele Stoffels, Norbert Galldiks, Ke Zhang, Michael Sabel, Heinrich Hubert Coenen, Nadim Joni Shah, Hans Herzog and Karl-Josef Langen

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 254;
You have access
Metabolic tumor volume by ¹⁸F-FDOPA PET is predictive of treatment response in patients with recurrent high-grade gliomas on anti-angiogenic therapy as early as 2 weeks after therapy initiation
Johannes Schwarzenberg, Timothy Cloughesy, Johannes Czernin, Benjamin Ellingson, Whitney Pope, Daniel Silverman, Cheri Geist, Michael Phelps and Wei Chen

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 250;
You have access
PET studies with a Ga-68-Bombesin analogue (BZH3) for the diagnostics of brain tumors and comparison to FDG
Antonia Dimitrakopoulou-Strauss, Marcel Seiz, Jochen Tuettenberg, Michael Eisenhut, Ludwig G. Strauss and Kirsten Schmieder

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 191;
You have access
Correlation of FDOPA-PET uptake with proliferative activity and malignancy grade in brain tumors
B Fueger, C Geist, Daniel Silverman, J Czernin, N Satyamurthy, A Lai, T Cloughesy, M Phelps and W Chen

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 189;
You have access
Pentavalent technetium-99m-dimercaptosuccinic acid [99mTc(V)-DMSA] brain SPECT versus proton magnetic resonance spectroscopy (1H-MRS) in assessment of glioma recurrence post radiotherapy
Ebaa Ahmed, Hosna Moustafa, Mohamed El-Tokhy and Amr Amin

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 190;
You have access
Presurgical evaluation of low grade gliomas using parametric images of FET-kinetics
Hans Herzog, Gabriele Stoffels, Lutz Tellmann, Heinz Coenen and Karl-Josef Langen

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 188;
You have access
Prediction of survival time using 18F-FLT kinetics and discriminant analysis in recurrent glioma therapy
M Wardak, C Schiepers, M Dahlbom, W Chen, T Cloughesy, J Czernin and S Huang

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 187;

Main menu

User menu

Search

More articles from Brain tumors

Pages